File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1001/archsurg.140.5.450
- Scopus: eid_2-s2.0-20944432143
- PMID: 15897440
- WOS: WOS:000228839600007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma
Title | Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma |
---|---|
Authors | |
Issue Date | 2005 |
Publisher | American Medical Association. The Journal's web site is located at http://www.archsurg.com |
Citation | Archives Of Surgery, 2005, v. 140 n. 5, p. 450-458 How to Cite? |
Abstract | Hypothesis: A subset of patients with hepatocellular carcinoma (HCC) with a diameter of 10 cm or larger may benefit from hepatic resection. Design: Retrospective study of a multi-institutional database. Setting: Five major hepatobiliary centers. Patients: We identified 300 patients who underwent hepatic resection for HCC 10 cm or larger. Main Outcome Measures: Clinical and pathologic data were collected, and prognostic factors were evaluated by univariate and multivariate analyses. Patient survival was stratified according to a clinical scoring system and pathologic T classification. Results: The perioperative mortality rate was 5%. At a median follow-up of 32 months, the median survival was 20.3 months, and the 5-year actuarial survival rate was 27%. Four clinical factors-α-fetoprotein of 1000 ng/mL or higher, multiple tumor nodules, the presence of major vascular invasion, and the presence of severe fibrosis-were significant predictors of poor survival (all P<.05). Patients were assigned a clinical score according to the following risk factors: 1, no factor; 2, one or two factors; or 3, three or four factors. On the basis of the clinical score, patients could be stratified into only 2 distinct prognostic groups: no factor (score of 1) vs 1 or more factors (score of 2 or 3) (P<.001). In contrast, when patients were stratified according to pathologic T classification, 3 distinct groups were identified: T1 vs T2 vs T3 and T4 combined (P<.001). Fifty-six percent of the patients with a clinical score of 2 and 20% of patients with a clinical score of 3 actually had T1 or T2 disease on pathologic examination. Conclusions: Patients with large HCCs should be considered for liver resection as this treatment is associated with a 5-year survival rate exceeding 25%. Clinical predictors should not be used to exclude patients from surgical resection because these factors do not reliably predict outcome. |
Persistent Identifier | http://hdl.handle.net/10722/88774 |
ISSN | 2014 Impact Factor: 4.926 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pawlik, TM | en_HK |
dc.contributor.author | Poon, RT | en_HK |
dc.contributor.author | Abdalla, EK | en_HK |
dc.contributor.author | Zorzi, D | en_HK |
dc.contributor.author | Ikai, I | en_HK |
dc.contributor.author | Curley, SA | en_HK |
dc.contributor.author | Nagorney, DM | en_HK |
dc.contributor.author | Belghiti, J | en_HK |
dc.contributor.author | OiLin Ng, I | en_HK |
dc.contributor.author | Yamaoka, Y | en_HK |
dc.contributor.author | Lauwers, GY | en_HK |
dc.contributor.author | Vauthey, JN | en_HK |
dc.contributor.author | Brems, J | en_HK |
dc.contributor.author | Ridee, B | en_HK |
dc.contributor.author | Helton, S | en_HK |
dc.contributor.author | Bilchik, A | en_HK |
dc.contributor.author | Chapman, W | en_HK |
dc.date.accessioned | 2010-09-06T09:47:48Z | - |
dc.date.available | 2010-09-06T09:47:48Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | Archives Of Surgery, 2005, v. 140 n. 5, p. 450-458 | en_HK |
dc.identifier.issn | 0004-0010 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/88774 | - |
dc.description.abstract | Hypothesis: A subset of patients with hepatocellular carcinoma (HCC) with a diameter of 10 cm or larger may benefit from hepatic resection. Design: Retrospective study of a multi-institutional database. Setting: Five major hepatobiliary centers. Patients: We identified 300 patients who underwent hepatic resection for HCC 10 cm or larger. Main Outcome Measures: Clinical and pathologic data were collected, and prognostic factors were evaluated by univariate and multivariate analyses. Patient survival was stratified according to a clinical scoring system and pathologic T classification. Results: The perioperative mortality rate was 5%. At a median follow-up of 32 months, the median survival was 20.3 months, and the 5-year actuarial survival rate was 27%. Four clinical factors-α-fetoprotein of 1000 ng/mL or higher, multiple tumor nodules, the presence of major vascular invasion, and the presence of severe fibrosis-were significant predictors of poor survival (all P<.05). Patients were assigned a clinical score according to the following risk factors: 1, no factor; 2, one or two factors; or 3, three or four factors. On the basis of the clinical score, patients could be stratified into only 2 distinct prognostic groups: no factor (score of 1) vs 1 or more factors (score of 2 or 3) (P<.001). In contrast, when patients were stratified according to pathologic T classification, 3 distinct groups were identified: T1 vs T2 vs T3 and T4 combined (P<.001). Fifty-six percent of the patients with a clinical score of 2 and 20% of patients with a clinical score of 3 actually had T1 or T2 disease on pathologic examination. Conclusions: Patients with large HCCs should be considered for liver resection as this treatment is associated with a 5-year survival rate exceeding 25%. Clinical predictors should not be used to exclude patients from surgical resection because these factors do not reliably predict outcome. | en_HK |
dc.language | eng | en_HK |
dc.publisher | American Medical Association. The Journal's web site is located at http://www.archsurg.com | en_HK |
dc.relation.ispartof | Archives of Surgery | en_HK |
dc.subject.mesh | Actuarial Analysis | en_HK |
dc.subject.mesh | Carcinoma, Hepatocellular - mortality - surgery | en_HK |
dc.subject.mesh | Databases, Factual | en_HK |
dc.subject.mesh | Female | en_HK |
dc.subject.mesh | Follow-Up Studies | en_HK |
dc.subject.mesh | Hepatectomy | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Liver - pathology | en_HK |
dc.subject.mesh | Liver Neoplasms - mortality - surgery | en_HK |
dc.subject.mesh | Male | en_HK |
dc.subject.mesh | Middle Aged | en_HK |
dc.subject.mesh | Prognosis | en_HK |
dc.subject.mesh | Retrospective Studies | en_HK |
dc.subject.mesh | Risk Factors | en_HK |
dc.subject.mesh | Survival Rate | en_HK |
dc.subject.mesh | Time Factors | en_HK |
dc.subject.mesh | alpha-Fetoproteins - analysis | en_HK |
dc.title | Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0004-0010&volume=140&issue=5&spage=450&epage=457&date=2005&atitle=Critical+appraisal+of+the+clinical+and+pathologic+predictors+of+survival+after+resection+of+large+hepatocellular+carcinoma | en_HK |
dc.identifier.email | Poon, RT: poontp@hkucc.hku.hk | en_HK |
dc.identifier.email | OiLin Ng, I: iolng@hkucc.hku.hk | en_HK |
dc.identifier.authority | Poon, RT=rp00446 | en_HK |
dc.identifier.authority | OiLin Ng, I=rp00335 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1001/archsurg.140.5.450 | en_HK |
dc.identifier.pmid | 15897440 | - |
dc.identifier.scopus | eid_2-s2.0-20944432143 | en_HK |
dc.identifier.hkuros | 99725 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-20944432143&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 140 | en_HK |
dc.identifier.issue | 5 | en_HK |
dc.identifier.spage | 450 | en_HK |
dc.identifier.epage | 458 | en_HK |
dc.identifier.isi | WOS:000228839600007 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Pawlik, TM=7006249269 | en_HK |
dc.identifier.scopusauthorid | Poon, RT=7103097223 | en_HK |
dc.identifier.scopusauthorid | Abdalla, EK=7006112354 | en_HK |
dc.identifier.scopusauthorid | Zorzi, D=8394976400 | en_HK |
dc.identifier.scopusauthorid | Ikai, I=7006764463 | en_HK |
dc.identifier.scopusauthorid | Curley, SA=7006597814 | en_HK |
dc.identifier.scopusauthorid | Nagorney, DM=35400419300 | en_HK |
dc.identifier.scopusauthorid | Belghiti, J=35403099400 | en_HK |
dc.identifier.scopusauthorid | OiLin Ng, I=7102753722 | en_HK |
dc.identifier.scopusauthorid | Yamaoka, Y=7201994050 | en_HK |
dc.identifier.scopusauthorid | Lauwers, GY=35391239300 | en_HK |
dc.identifier.scopusauthorid | Vauthey, JN=35270590000 | en_HK |
dc.identifier.scopusauthorid | Brems, J=7006399126 | en_HK |
dc.identifier.scopusauthorid | Ridee, B=8394977500 | en_HK |
dc.identifier.scopusauthorid | Helton, S=6603638012 | en_HK |
dc.identifier.scopusauthorid | Bilchik, A=7004799381 | en_HK |
dc.identifier.scopusauthorid | Chapman, W=7203062191 | en_HK |
dc.identifier.issnl | 0004-0010 | - |